Article Versions Notes

Rahim NS, Wu YS, Sim MS, Velaga A, Bonam SR, Gopinath SCB, Subramaniyan V, Choy KW, Teow S-Y, Fareez IM, et al. Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance. Pharmaceuticals. 2023; 16(1):110. https://doi.org/10.3390/ph16010110

Rahim, Nur Syafiqah, Yuan Seng Wu, Maw Shin Sim, Appalaraju Velaga, Srinivasa Reddy Bonam, Subash C. B. Gopinath, Vetriselvan Subramaniyan, Ker Woon Choy, Sin-Yeang Teow, Ismail M. Fareez, and et al. 2023. "Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance" Pharmaceuticals 16, no. 1: 110. https://doi.org/10.3390/ph16010110

Rahim, N. S., Wu, Y. S., Sim, M. S., Velaga, A., Bonam, S. R., Gopinath, S. C. B., Subramaniyan, V., Choy, K. W., Teow, S. -Y., Fareez, I. M., Samudi, C., Sekaran, S. D., Sekar, M., & Guad, R. M. (2023). Three Members of Transmembrane-4-Superfamily, TM4SF1, TM4SF4, and TM4SF5, as Emerging Anticancer Molecular Targets against Cancer Phenotypes and Chemoresistance. Pharmaceuticals, 16(1), 110. https://doi.org/10.3390/ph16010110